相关实验视频

Updated: May 26, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

在癌症治疗中通过疏水性聚合物标记纳米粒子进行向蛋白质降解

Seohee Lee¹, Seonwoo Kang¹, Won Jong Kim^1,2

¹Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.

|February 21, 2025

概括

我们开发了用于向蛋白质降解 (TPD) 的聚合物纳米粒子,克服了传统药物的局限性. 这种纳米技术平台增强了溶解性,瘤向性,并减少了潜在的通用蛋白质降解疗法的耐药性.

科学领域:

生物技术是生物技术.
纳米医学是一种纳米医学.
药物运输药物运输药物运输

背景情况:

向蛋白质降解 (TPD) 通过降解致病蛋白质,减少复发和耐药性,为传统抑制剂提供了优势.
双功能TPD分子面临的挑战包括溶解性差,生物可用性和瘤特异性.

研究的目的:

开发一种基于聚合物的纳米粒子系统,将TPD策略与纳米技术结合起来,以提高蛋白质降解和输送.
通过提高溶解性,稳定性和瘤向性来解决当前TPD分子的局限性.

主要方法:

开发的聚合物纳米颗粒使用疏水标记方法与块共聚合物 (ARL-PLA-SS-PEG).
区块共聚合物形成,在可还原的细胞环境中降解,释放TPD剂.
使用一种与聚乳酸 (PLA) 和聚乙烯糖醇 (PEG) 结合的雄激素受体配体 (ARL).

主要成果:

使用开发的小粒体,证明了在体外显著降解雄激素受体 (AR).
在携带瘤的小鼠模型中实现了大量的瘤积累和显著的瘤生长抑制.
机理学研究表明,小胞介导的TPD遵循双重途径,涉及蛋白酶和自酶.

结论:

开发的基于聚合物的纳米颗粒为向蛋白质降解提供了一个有前途的平台.
这种方法提高了溶解性,稳定性和瘤向性,可能成为蛋白质降解疗法的通用平台.
该系统克服了传统TPD分子的局限性,减少了对疾病特定药物开发的需求.

关键词:

疏水标签是指疏水的标签纳米颗粒是一种纳米粒子.自动组装的自动组装机有针对性的蛋白质降解降解.瘤是一个瘤.

更多相关视频

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Regulated Protein Degradation

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...